Abstract
The goal of this chapter is to give a comprehensive overview of selection criteria, surgical technique and operative outcomes of standard Bilio-Pancreatic Diversion with Duodenal Switch (BPD-DS) as a second-stage procedure for failed Sleeve Gastrectomy (SG). The importance of vitamin supplementation and long-term clinical and metabolic follow-up is also emphasized. 90-day major complication rate of 2-stage DS is around 5%, not significantly different from single-stage BPD-DS. Following second-stage DS, excess weight loss increases from 39 ± 17% after SG to 75 ± 18% at 1 year, 80.2 ± 17% at 2 years and 80.2 ± 18% at 3 years. Remission rate for Type 2 Diabetes (T2D) increases from 59% after SG to 94% and remission of hypertension increases from 42 to 77%. In addition, second-stage DS is highly effective in controlling patients with T2D on insulin, with a remission rate of 80% (from 15% after SG). Strong metabolic changes explain the excellent 10-years outcomes of single-stage BPD-DS, with a remission rate for T2D over 90%. Side-effects and nutritional risks, including an 8% readmission rate for protein de-nutrition after single-stage BPD-DS at 9 years is also discussed. Overall, second-stage BPD-DS offers the most effective weight loss and metabolic option in patients with SG failure who are willing to commit to long-term follow-up and vitamin supplementation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.
Unick JL, Beavers D, Bond DS, Clark JM, Jakicic JM, Kitabchi AE, et al. The long-term effectiveness of a lifestyle intervention in severely obese individuals. the Am J Med. 2013;126(3):236–42.
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. the New Engl J Med. 2012;366(17):1567–76.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. the New Engl J Med. 2014;370(21):2002–13.
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. the New Engl Journal of Medicine. 2012;366(17):1577–85.
Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.
Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3(1):29–35.
Biertho L, Marceau S, Biron S. A Canadian and historical perspective on bariatric surgery. Can J Diab. 2017;41(4):341–3.
Marceau P, Biron S, Marceau S, Hould FS, Lebel S, Lescelleur O, et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes Surg. 2015.
Biertho L, Lebel S, Marceau S, Hould FS, Lescelleur O, Marceau P, et al. Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases. Dig Surg. 2014;31(1):48–54.
Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017.
Information CIfH. Bariatric surgery in Canada 2014.
Rosenthal RJ, Diaz AA, Arvidsson D, Baker RS, Basso N, Bellanger D, et al. International sleeve gastrectomy expert panel consensus statement: best practice guidelines based on experience of >12,000 cases. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2012;8(1):8–19.
Gagner M, Hutchinson C, Rosenthal R. Fifth international consensus conference: current status of sleeve gastrectomy. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2016;12(4):750–6.
English WJ, DeMaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM. American society for metabolic and bariatric surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2018;14(3):259–63.
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.
Salminen P, Helmio M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P, et al. Effect of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241–54.
Peterli R, Wolnerhanssen BK, Peters T, Vetter D, Kroll D, Borbely Y, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. the New Engl J Med. 2017;376(7):641–51.
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.
Biertho L, Theriault C, Bouvet L, Marceau S, Hould FS, Lebel S, et al. Second-stage duodenal switch for sleeve gastrectomy failure: A matched controlled trial. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2018;14(10):1570–9.
Homan J, Betzel B, Aarts EO, van Laarhoven KJ, Janssen IM, Berends FJ. Secondary surgery after sleeve gastrectomy: Roux-en-Y gastric bypass or biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2015;11(4):771–7.
Iannelli A, Schneck AS, Topart P, Carles M, Hebuterne X, Gugenheim J. Laparoscopic sleeve gastrectomy followed by duodenal switch in selected patients versus single-stage duodenal switch for superobesity: case-control study. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2013;9(4):531–8.
Sanchez-Pernaute A, Rubio MA, Perez Aguirre E, Barabash A, Cabrerizo L, Torres A. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2013;9(5):731–5.
Sanchez-Pernaute A, Rubio MA, Conde M, Arrue E, Perez-Aguirre E, Torres A. Single-anastomosis duodenoileal bypass as a second step after sleeve gastrectomy. Surg Obes Relat Dis: Official J Am Soc Bariatric Surg. 2015;11(2):351–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Biertho, L., Marceau, S., Lebel, S., Julien, F., Tchernof, A. (2021). Revisional Surgery: Second-Stage Duodenal Switch. In: Al-Sabah, S., Aminian, A., Angrisani, L., Al Haddad, E., Kow, L. (eds) Laparoscopic Sleeve Gastrectomy. Springer, Cham. https://doi.org/10.1007/978-3-030-57373-7_55
Download citation
DOI: https://doi.org/10.1007/978-3-030-57373-7_55
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57372-0
Online ISBN: 978-3-030-57373-7
eBook Packages: MedicineMedicine (R0)